Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early Zidovudine in Asymptomatic HIV-Infected Infants
NCT00000750Phase 3Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 3, randomised, double-blind trial in human immunodeficiency virus infection (HIV) comparing Zidovudine with Placebo (2 arms). Primary endpoints: Efficacy of early treatment to prevent development of symptoms and Safety and tolerance of AZT. Status: completed.
02
Drugs
zidovudine
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT00000750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000750.